10A NCAC 27A .0212. CLOZAPINE

(a)  The Division shall administer a program for the reimbursement of area programs for the purchase of the drug Clozaril for the treatment of eligible clients suffering from schizophrenia.

(b)  Funds shall be used for the reimbursement for laboratory services, pharmacy dispensing fees and for the price of the drug identified as Clozapine or Clozaril.

(c)  Eligible clients shall be individuals who have a diagnosis of schizophrenia and are:

(1)           Medicaid eligible but have a spend down requirement (Division funds may be used during the spend down period and count toward the spend requirement);

(2)           not Medicaid eligible but who meet the federal poverty threshold;

(3)           discharged from a state psychiatric hospital on the drug Clozapine.

(d)  Funds shall be paid and settled in a manner prescribed by the Division Director.

 

History Note:        Authority G.S. 122C-141; 122C-143.1; 122C-143.2; 122C-147; 122C-147.1; 122C-147.2;

Eff. February 1, 1996.